▼ -0.12% Downside Potential
This price target is based on 17 analysts offering 12 month price targets for Ventas in the last 3 months. The average price target is $42.19, with a high forecast of $68.00 and a low forecast of $23.00. The average price target represents a -0.12% upside from the last price of $42.24.
The current consensus among 17 polled investment analysts is to hold stock in Ventas.
Ventas, Inc., an S&P 500 company, is a leading real estate investment trust. Its diverse portfolio of approximately 1,200 assets in the United States, Canada and the United Kingdom consists of seniors housing communities, medical office buildings, university-based research and innovation centers, inpatient rehabilitation and long-term acute care facilities, and health systems. Through its Lillibridge subsidiary, Ventas provides management, leasing, marketing, facility development and advisory services to highly rated hospitals and health systems throughout the United States. References to Ventas or the Company mean Ventas, Inc. and its consolidated subsidiaries unless otherwise expressly noted.